![Yao Lee](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Yao Lee
Director/Board Member at
INSMED INCORPORATED
Net worth: 6 M $ as of 2026-06-29
Profile
Yao Lee is currently an Independent Director at Insmed, Inc. since 2018, President & Representative Director at Novartis Pharma KK since 2020, and President at Merck Serono Co., Ltd. Former roles include President, Director & Senior Director at BIOVIA, Inc. from 1997 to 2003, Non-Executive Director at Regeneus Ltd. from 2020 to 2024, Vice President-Sales at Merck & Co., Inc. from 2008 to 2011, President-Japan at Merck KGaA from 2015 to 2017, GM, Vice President-APAC Sales & Marketing at IQVIA, Inc. from 2003 to 2008, and President-Japan at Allergan UC from 2011 to 2015.
Education includes undergraduate studies at the University of California, Los Angeles.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
INSMED INCORPORATED 0.03% | 2026-05-12 | 57,971 ( 0.03% ) | 6 M $ | 2026-06-29 |
Yao Lee active positions
| Companies | Position | Start |
|---|---|---|
| INSMED INCORPORATED | Director/Board Member | 2018-05-16 |
Merck Serono Co., Ltd. | President | - |
Novartis Pharma KK
 Novartis Pharma KK Pharmaceuticals: MajorHealth Technology Develops, imports, produces and markets pharmaceutical products | President | 2020-10-31 |
Former positions of Yao Lee
| Companies | Position | End |
|---|---|---|
| REGENEUS LTD | Chief Executive Officer | 2020-11-01 |
| MERCK KGAA | Corporate Officer/Principal | 2016-12-31 |
| ALLERGAN PLC | Corporate Officer/Principal | 2014-12-31 |
| MERCK & CO., INC. | Sales & Marketing | 2010-12-31 |
| IMS HEALTH, INC. | Corporate Officer/Principal | 2007-12-31 |
Training of Yao Lee
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
64
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
BIOVIA, Inc.
 BIOVIA, Inc. Packaged SoftwareTechnology Services Develops cloud-based and enterprise R&D, modeling and informatics platform | Technology Services |
Merck KGaA
 Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products | Health Technology |
IQVIA, Inc.
 IQVIA, Inc. Packaged SoftwareTechnology Services Provides AI assistant, analytics and clinical research services for healthcare sector | Technology Services |
Insmed, Inc.
 Insmed, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases | Health Technology |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Allergan Ltd. (Ireland)
 Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes pharmaceuticals, devices, biological, surgical & regenerative medicine products | Health Technology |
Novartis Pharma KK
Novartis Pharma KK Pharmaceuticals: MajorHealth Technology Develops, imports, produces and markets pharmaceutical products | Health Technology |
Merck Serono Co., Ltd. | |
Regeneus Ltd.
 Regeneus Ltd. Pharmaceuticals: MajorHealth Technology Develops innovative cell-based therapies to unmet medical needs in human and veterinary health | Health Technology |
- Stock Market
- Insiders
- Yao Lee
